ArchiveSCV
the-signal.com. The Santa Clarita Valley Signal. Back to the collection.

· signalscv.com, Wayback capture

MannKind Also listing on Tel Aviv Stock Exchange

Valencia biomedical company, MannKind, announced Friday that the Tel Aviv Stock Exchange approved listing common shares of MannKind under the ticker symbol MNKD.

MannKind is creator of the insulin treatment, Afrezza, approved by the FDA last year.

Listing on the Israeli exchange represents a dual listing for the company. It’s also listed on the U.S.-based Nasdaq exchange. The listing takes effect Oct. 28.

Shares of the company’s stock are expected to be included in five of the Israeli equity indexes, one of which is a biomed index.

"The new listing also offers an opportunity to expand and diversify our shareholder base by increasing our exposure and improving our accessibility to Israeli investors," said Hakan Edstrom, president and CEO of MannKind.

Alfred Mann, executive chairman, has had a long-standing relationship with the Israeli biotechnology industry, Edstrom said.

← Back to 2015

About this record

How it was held, read and classified

Record details

Morris ID
143957
System
Morris section CMS (/section/…/article/… and /archives/…)
Reading copy
signalscv.com
Chosen by: only copy held. On this copy: words 136 (e-mail addresses counted as one token); reader comments 0 (counted, not reproduced here); images 0.
Extracted by
section_cms:articlebody_span
signal-extract/0.15 (2026-11-16)

Other copies

Held
None. The holding has this article from one host only.

How it was classified

Label
clearly-local
Judgment
A machine’s (recorded as machine), kept as one so it can be revisited.
Classifier
signal-localclass/0.7 (2026-11-12)
Local signals
  • url:section_24_local
  • byline:staff_marker [Signal Staff]
  • text:valley_names [1 distinct/1 mentions: Valencia]
National signals
none fired
Scores
local 7, national 0